HC Wainwright Has Strong Estimate for Altimmune Q2 Earnings
Altimmune, Inc. (NASDAQ:ALT – Free Report) – HC Wainwright upped their Q2 2025 earnings estimates for Altimmune in a research report issued to clients and investors on Thursday, May 15th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings of ($0.33) per share for the quarter, up from their prior estimate […]
Altimmune, Inc. (NASDAQ:ALT – Free Report) – HC Wainwright upped their Q2 2025 earnings estimates for Altimmune in a research report issued to clients and investors on Thursday, May 15th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings of ($0.33) per share for the quarter, up from their prior estimate […]
